Imagine a world where rare diseases are no longer a mystery. That is the mission of Sobi. Sobi is located right here in Massachusetts.
Sobi is an international specialty healthcare company. It focuses on developing treatments. Sobi also creates patient support networks. These are for people with rare and difficult to treat diseases.
Sobi recognizes that these patients are often misunderstood. They may be misdiagnosed. They might have limited medical options. Sobi’s commitment has led to world-class capabilities. These are in protein biochemistry and biologics manufacturing. Industry partners recognize these capabilities.
Sobi established its North American operations in Waltham, Massachusetts in 2014. Before that, Sobi had a US affiliate in Ardmore, Pennsylvania starting in 2012. The opening of the office was on June 16, 2014.
Geoffrey McDonough was the CEO and President of Sobi. He said they were strengthening their focus in the United States and Canada. Building a team in the Boston area would allow them to address patient and healthcare provider needs. Sobi partners with the Massachusetts Life Sciences Center.
Governor Deval Patrick welcomed Sobi to Massachusetts. He looked forward to their contributions to the thriving life sciences community. Massachusetts is a leader in life sciences. This is due to the growth strategy of investing in education, innovation, and infrastructure.
Rami Levin is the Vice President North America, Sobi. He said Massachusetts has one of the largest concentrations of biotech activity in the world. The region has a broad-based biotech industry segment. Massachusetts is a major driver for global biotechnology innovation. There is a strong talent pool here. This offers the opportunity to collaborate with research institutions and universities.
Sobi worked with the Massachusetts Life Sciences Center. They developed their plans for the Massachusetts office. Susan Windham-Bannister is the President & CEO of the Massachusetts Life Sciences Center. She welcomed Sobi. She said Sobi is an excellent addition to local companies. These companies improve the lives of patients with rare diseases.
Sobi’s product portfolio focuses on inflammation and genetic diseases. They have late-stage biological development projects within Hemophilia. Sobi also markets specialty and rare disease products for partner companies.
Sobi took direct responsibility for commercializing Orfadin in North America. Orfadin is an FDA-approved therapy. It is for use with dietary restrictions. It helps treat hereditary tyrosinemia type 1 or HT-1.
Sobi contributes to societies by improving access to treatment for rare diseases. Every day, they work to find better ways to meet patient needs. Sobi provides access to innovative treatments. These treatments transform the lives of people. Their therapies are concentrated in Haematology, Immunology and Specialty Care.
So, as you pass by, remember Sobi. They are dedicated to improving lives. They focus on rare diseases. They are a pioneer in biotechnology right here in Massachusetts.